![[2602.15451] Molecular Design beyond Training Data with Novel Extended Objective Functionals of Generative AI Models Driven by Quantum Annealing Computer](https://arxiv.org/static/browse/0.3.4/images/arxiv-logo-fb.png){kind=logo}
[2602.15451] Molecular Design beyond Training Data with Novel Extended Objective Functionals of Generative AI Models Driven by Quantum Annealing Computer
Summary
This article presents a novel framework for optimizing deep generative models in molecular design using quantum annealing, significantly enhancing drug-likeness in generated compounds.
Why It Matters
The integration of quantum computing with generative AI models represents a significant advancement in drug discovery, addressing the challenge of generating drug-like compounds. This research could accelerate the development of effective pharmaceuticals, impacting healthcare and biotechnology sectors.
Key Takeaways
- The proposed framework improves drug-like compound generation beyond traditional models.
- Quantum annealing enhances the optimization process in molecular design.
- The Neural Hash Function serves dual purposes in model regularization and signal transformation.
- Results indicate a higher quality of generated compounds compared to classical methods.
- This approach may revolutionize drug discovery by expanding the feature space in molecular design.
Quantitative Biology > Quantitative Methods arXiv:2602.15451 (q-bio) [Submitted on 17 Feb 2026] Title:Molecular Design beyond Training Data with Novel Extended Objective Functionals of Generative AI Models Driven by Quantum Annealing Computer Authors:Hayato Kunugi, Mohsen Rahmani, Yosuke Iyama, Yutaro Hirono, Akira Suma, Matthew Woolway, Vladimir Vargas-Calderón, William Kim, Kevin Chern, Mohammad Amin, Masaru Tateno View a PDF of the paper titled Molecular Design beyond Training Data with Novel Extended Objective Functionals of Generative AI Models Driven by Quantum Annealing Computer, by Hayato Kunugi and 10 other authors View PDF Abstract:Deep generative modeling to stochastically design small molecules is an emerging technology for accelerating drug discovery and development. However, one major issue in molecular generative models is their lower frequency of drug-like compounds. To resolve this problem, we developed a novel framework for optimization of deep generative models integrated with a D-Wave quantum annealing computer, where our Neural Hash Function (NHF) presented herein is used both as the regularization and binarization schemes simultaneously, of which the latter is for transformation between continuous and discrete signals of the classical and quantum neural networks, respectively, in the error evaluation (i.e., objective) function. The compounds generated via the quantum-annealing generative models exhibited higher quality in both validity and drug-likene...
